Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich plasma added to balloon and hormone therapy after hysteroscopic adhesiolysis for prevention of recurrent intrauterine adhesions
PACTR202608799641676Not yet recruiting
- Sponsor
- Chioma Opara
- Start
- Sep 2026
- Countries
- 1
01
Overview
Trial of platelet-rich plasma, sponsored by Chioma Opara. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
platelet-rich plasma
Beyond the preview
Go deeper on PACTR202608799641676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608799641676.